| Doxycycline Monohydrate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Doxycycline Monohydrate monohydrate 75 mg | tablet | oral | 1.0 each | OTC |
| Doxycycline Monohydrate monohydrate 50 mg | tablet | oral | 1.0 each | OTC |
| Doxycycline Monohydrate monohydrate 100 mg | tablet | oral | 1.0 each | OTC |
| Doxycycline Monohydrate monohydrate 100 mg | capsule | oral | 1.0 each | OTC |
| Doxycycline Monohydrate monohydrate 50 mg | capsule | oral | 1.0 each | OTC |
Posted by maryj1000 2 months ago
I've only taken 1 dosage about 5 hours ago for a infected cat bite and I feel soooooooooooooooooo tired. I believe that the ...
Posted by xeu 3 months ago
I feel like I am SO tired on doxycycline. I'm on it for Lyme disease, had Rx for 3 weeks, was off it a week and started to ha...
Posted by chrisbarnes1 about 1 year ago
I see that of only 2 postings as of this one from me, one mentions feeling "generalized weakness and fatigue." BINGO! Me ...
Bradley Pharmaceuticals Launches Authorized Generic of ADOXA® - Pharmaceutical Processing
Bradley Pharmaceuticals, Inc., recently announced the launch of its authorized generic version for ADOXA® 150 mg strength doxycycline monohydrate tablets. ...
Tue Jun 19 12:01:06 -0400 2007
Bradley Pharmaceuticals Launches Authorized Generic of ADOXA(R) - PR Newswire (press release)
... Inc. (NYSE: BDY) today announced the launch of its authorized generic version for ADOXA(R) 150 mg strength doxycycline monohydrate tablets. ...
Tue Jun 12 06:00:08 -0400 2007
First Busey, Main Street Trust Deal Clears US Antitrust Hurdle ... - RTT News
... PM Bradley Pharmaceuticals Inc. (BDY) announced the launch of its authorized generic version for ADOXA 150 mg strength doxycycline monohydrate tablets. ...
Tue Jun 12 11:31:27 -0400 2007
doxycycline monohydrate - The monohydrate form of doxycycline exhibiting antimicrobial activity. Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. (NCI)